Johnson & Johnson is trimming its sales force for anemia drug Procrit, a top-seller that has lost market share recently due to increased competition from Amgen’s Aranesp. Ortho Biotech Products, the J ...
Dear Dr. Roach: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...
DEAR DR. ROACH: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...
DEAR DR. ROACH: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback